Morgan Stanley Pulmonx Corp Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Pulmonx Corp stock. As of the latest transaction made, Morgan Stanley holds 3,072,838 shares of LUNG stock, worth $27.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,072,838

Previous 3,788,945 18.9%

Holding current value

$27.5 Million

Previous $31.4 Million 33.58%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$5.93 - $7.71 $4.25 Million - $5.52 Million	-716,107 Reduced 18.9%	3,072,838 $20.9 Million
Q3 2024 Nov 14, 2024	BUY	$5.59 - $8.58 $1.78 Million - $2.73 Million	317,868 Added 9.16%	3,788,945 $31.4 Million
Q2 2024 Oct 17, 2024	BUY	$5.77 - $9.82 $4.73 Million - $8.05 Million	819,632 Added 30.91%	3,471,077 $22 Million
Q2 2024 Aug 14, 2024	BUY	$5.77 - $9.82 $4.73 Million - $8.05 Million	819,632 Added 30.91%	3,471,077 $22 Million
Q1 2024 Oct 17, 2024	SELL	$8.71 - $14.65 $7.14 Million - $12 Million	-819,632 Reduced 23.61%	2,651,445 $24.6 Million
Q1 2024 Aug 16, 2024	BUY	$8.71 - $14.65 $3.25 Million - $5.46 Million	372,724 Added 16.36%	2,651,445 $24.6 Million
Q1 2024 May 15, 2024	BUY	$8.71 - $14.65 $3.25 Million - $5.46 Million	372,724 Added 16.36%	2,651,445 $24.6 Million
Q4 2023 Aug 16, 2024	SELL	$7.89 - $13.14 $9.41 Million - $15.7 Million	-1,192,356 Reduced 34.35%	2,278,721 $29.1 Million
Q4 2023 Feb 13, 2024	BUY	$7.89 - $13.14 $464,681 - $773,880	58,895 Added 2.65%	2,278,721 $29.1 Million
Q3 2023 Nov 15, 2023	BUY	$9.88 - $14.0 $2.43 Million - $3.45 Million	246,302 Added 12.48%	2,219,826 $22.9 Million
Q2 2023 Aug 14, 2023	SELL	$10.78 - $13.65 $6.91 Million - $8.75 Million	-640,847 Reduced 24.51%	1,973,524 $25.9 Million
Q1 2023 May 15, 2023	BUY	$7.49 - $12.54 $3.47 Million - $5.82 Million	463,866 Added 21.57%	2,614,371 $29.2 Million
Q4 2022 Feb 14, 2023	BUY	$4.92 - $17.35 $1.46 Million - $5.15 Million	296,682 Added 16.0%	2,150,505 $18.1 Million
Q3 2022 Nov 14, 2022	SELL	$15.35 - $23.99 $4.21 Million - $6.57 Million	-273,948 Reduced 12.87%	1,853,823 $30.9 Million
Q2 2022 Oct 27, 2022	BUY	$14.0 - $27.95 $26.6 Million - $53 Million	1,897,698 Added 824.82%	2,127,771 $31.3 Million
Q2 2022 Aug 15, 2022	BUY	$14.0 - $27.95 $26.6 Million - $53 Million	1,897,698 Added 824.82%	2,127,771 $31.3 Million
Q1 2022 Oct 27, 2022	SELL	$21.13 - $35.65 $40.1 Million - $67.7 Million	-1,897,698 Reduced 89.19%	230,073 $5.71 Million
Q1 2022 May 13, 2022	BUY	$21.13 - $35.65 $3.44 Million - $5.81 Million	163,024 Added 243.14%	230,073 $5.71 Million
Q4 2021 Feb 14, 2022	BUY	$29.72 - $45.1 $1.43 Million - $2.17 Million	48,171 Added 255.17%	67,049 $2.15 Million
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $679,230 - $839,693	18,878 New	18,878 $680,000

Others Institutions Holding LUNG

# of Institutions

130

Shares Held

31.4M

Call Options Held

500

Put Options Held

213K

View Full List

About Pulmonx Corp

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $334M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

More about LUNG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account